ArticleMolecular cancer therapeutics2012
Modulation of Akt/mTOR signaling overcomes sunitinib resistance in renal and prostate cancer cells.
Peter B Makhov et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
57 papers cite it
this papercites it